Masimo Future Growth
Future criteria checks 4/6
Masimo is forecast to grow earnings and revenue by 25.1% and 5.9% per annum respectively while EPS is expected to grow by 24% per annum.
Key information
25.1%
Earnings growth rate
24.0%
EPS growth rate
Medical Equipment earnings growth | 23.1% |
Revenue growth rate | 5.9% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 10 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,366 | 202 | 395 | 463 | 9 |
12/31/2025 | 2,229 | 168 | 277 | 351 | 10 |
12/31/2024 | 2,100 | 100 | 220 | 272 | 10 |
6/29/2024 | 2,017 | 79 | 111 | 190 | N/A |
3/30/2024 | 1,976 | 79 | 51 | 140 | N/A |
12/30/2023 | 2,048 | 82 | 6 | 94 | N/A |
9/30/2023 | 2,116 | 89 | -58 | 10 | N/A |
7/1/2023 | 2,187 | 116 | -28 | 28 | N/A |
4/1/2023 | 2,297 | 118 | -45 | 7 | N/A |
12/31/2022 | 2,036 | 144 | -27 | 29 | N/A |
10/1/2022 | 1,746 | 171 | 78 | 134 | N/A |
7/2/2022 | 1,505 | 191 | 147 | 205 | N/A |
4/2/2022 | 1,244 | 223 | 181 | 229 | N/A |
1/1/2022 | 1,239 | 230 | 230 | 265 | N/A |
10/2/2021 | 1,207 | 232 | 188 | 232 | N/A |
7/3/2021 | 1,177 | 224 | 149 | 190 | N/A |
4/3/2021 | 1,173 | 229 | 176 | 228 | N/A |
1/2/2021 | 1,144 | 240 | 131 | 211 | N/A |
9/26/2020 | 1,096 | 223 | 138 | 217 | N/A |
6/27/2020 | 1,047 | 222 | 148 | 227 | N/A |
3/28/2020 | 976 | 211 | 119 | 222 | N/A |
12/28/2019 | 938 | 196 | 149 | 222 | N/A |
9/28/2019 | 913 | 190 | 150 | 215 | N/A |
6/29/2019 | 895 | 198 | 153 | 212 | N/A |
3/30/2019 | 877 | 197 | 187 | 210 | N/A |
12/29/2018 | 858 | 194 | 217 | 240 | N/A |
9/29/2018 | 843 | 139 | 201 | 225 | N/A |
6/30/2018 | 826 | 118 | 149 | 199 | N/A |
3/31/2018 | 807 | 119 | N/A | 114 | N/A |
12/30/2017 | 790 | 125 | N/A | 56 | N/A |
9/30/2017 | 766 | 348 | N/A | 338 | N/A |
7/1/2017 | 740 | 340 | N/A | 347 | N/A |
4/1/2017 | 720 | 325 | N/A | 414 | N/A |
12/31/2016 | 713 | 311 | N/A | 419 | N/A |
10/1/2016 | 672 | 109 | N/A | 150 | N/A |
7/2/2016 | 657 | 101 | N/A | 145 | N/A |
4/2/2016 | 640 | 90 | N/A | 117 | N/A |
1/2/2016 | 623 | 83 | N/A | 117 | N/A |
10/3/2015 | 623 | 80 | N/A | 85 | N/A |
7/4/2015 | 613 | 76 | N/A | 86 | N/A |
4/4/2015 | 596 | 70 | N/A | 91 | N/A |
1/3/2015 | 580 | 73 | N/A | 96 | N/A |
9/27/2014 | 556 | 61 | N/A | 73 | N/A |
6/28/2014 | 545 | 61 | N/A | 61 | N/A |
3/29/2014 | 543 | 65 | N/A | 54 | N/A |
12/28/2013 | 541 | 58 | N/A | 55 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0JZ2's forecast earnings growth (25.1% per year) is above the savings rate (1.9%).
Earnings vs Market: 0JZ2's earnings (25.1% per year) are forecast to grow faster than the UK market (14% per year).
High Growth Earnings: 0JZ2's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 0JZ2's revenue (5.9% per year) is forecast to grow faster than the UK market (3.5% per year).
High Growth Revenue: 0JZ2's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0JZ2's Return on Equity is forecast to be high in 3 years time